Director, Quality Control

Our commitment to people with neuromuscular diseases

Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1) as well as a preclinical programs for facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease.

At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities. Learn more at  , and follow us on X , Linked In and Facebook .

The Director, Quality Control leads global Quality Control activities, including oversight of external laboratories supporting analytical testing, release, and stability programs across clinical and commercial stages. Provides strategic direction and operational leadership to ensure compliant, efficient, and high‑quality execution of QC activities from early development through BLA and commercialization. Drives cross‑functional alignment and external partnership performance while shaping the QC function to meet evolving organizational and regulatory requirements.

This is an onsite role based in Waltham, MA.

• Defines and executes the strategic vision for the Quality Control function to support clinical and commercial programs
• Establishes organizational structure, capabilities, and processes to support growth and future commercialization
• Participates in Pharmaceutical Quality leadership team activities, contributing to functional goals, priorities, and budgets
• Leads and develops QC personnel, including oversight of training, performance, and team development

• Oversees external QC laboratories, including testing execution, data analysis, and issuance of Certificates of Analysis
• Defines, tracks, and trends laboratory performance metrics (e.g., quality, capacity, turnaround time, non‑conformances) to drive partner accountability and continuous improvement
• Leads analytical troubleshooting efforts in collaboration with contract laboratories
• Ensures alignment of external partners with program timelines to enable product disposition

• Reviews and approves analytical method qualification and validation protocols and reports
• Authors, reviews, and approves stability protocols and reports and supports assignment of product expiry
• Supports establishment of critical quality attributes (CQAs) and product specifications for Drug Substance (DS) and Drug Product (DP)
• Partners with QA to ensure effective oversight of cGMP QC activities, including change control, deviations, investigations, CAPAs, and batch disposition support
• Leads Out of Specification (OOS) and Out of Trend (OOT) investigations
• Authors, reviews, and approves QC standard operating procedures

• Prepares and reviews analytical CMC content for regulatory submissions (INDs, BLAs) and supports interactions with global health authorities
• Participates in regulatory inspections and ensures inspection readiness across QC activities
• Collaborates closely with Quality Assurance, Manufacturing, CMC, Supply Chain, Regulatory Affairs, and Project Management to align quality and program objectives
• Oversees stability and reference standard programs to ensure compliance with regulatory expectations

Bachelor’s degree in Biology, Biochemistry, Chemistry, or related discipline; advanced degree (PhD) in Chemistry or Analytical Chemistry strongly preferred

12+ years of experience in Analytical Development and/or Quality Control within a GMP‑regulated environment

Strong expertise in analytical techniques (e.g., SEC, AEX, RP‑HPLC, CE‑SDS, icIEF, ELISA)

Deep knowledge of cGMP regulations and global guidance (FDA, ICH, EU)

Experience with compendial and product‑specific analytical methods for biologics and/or small…